Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • How you can fix common problems

    The relationship between IRBs and principal investigators often seems strained and adversarial, but IRB and research experts say the problems mostly can be solved with a few creative changes.
  • Eliminating barriers to effective discussion between PIs and IRBs

    Attendees to the 2004 Annual IRB Conference, sponsored by the Public Responsibility in Medicine and Research and held Oct. 28-31 in San Diego, will find a great deal of discussion about improving communication between IRBs and principal investigators in both biomedical and social-behavioral research areas. IRB Advisor spoke to several people who are scheduled to be PRIM&R panel members before the conference convened in late October, and this issue features stories that explore how to remove communication barriers and strategies for improving the relationship between PIs and IRBs, as well as strategies for helping the IRB process run more smoothly.
  • Working with social- behavioral researchers

    One possible explanation for why IRB reviews of social-behavioral research pose complications and some confusion among IRBs and researchers can be found in the very different mindsets of the two parties.
  • Self-assessment can point to needed changes 

    Copernicus Group IRB of Cary, NC, sought accreditation to validate that the 8-year-old, independent IRB and human research protection program was on the right track with its human research protection program.
  • Full November 2004 issue in PDF

  • Journal editors issue new requirements 

    Pharmaceutical researchers will have to register their clinical trials with a publicly accessible database if they expect to ever publish their findings in a top-flight medical journal, according to new requirements issued Sept. 8 by the International Committee of Medical Journal Editors (ICMJE).
  • COI disclosure not a surefire remedy 

    IRBs may want to re-think their policies on evaluating research conflicts of interest in light of new studies indicating disclosure may not have its intended effect.
  • Clinical Briefs in Primary Care

    Functional Decline in Peripheral Arterial Disease; Topical Capsaicin for Chronic Pain; Topical Tacrolimus Therapy for Vitiligo; US Prevalence and Impact on Axillary Hyperhidrosis; Mortality and Incidence of Cancer During 10-Year Follow-Up of the Scandinavian Simvastatin Survival Study (4S); Effects of Extended Outpatient Rehabilitation After Hip Fracture.
  • Full November 2004 issue in PDF

  • Latex allergy update: Is powder-free carefree?

    With low-protein, powder-free latex gloves available, has the issue of latex allergy been resolved? For some hospitals, changes in products have reduced new employee sensitivities almost to zero. Other hospitals are still seeking alternatives to latex to create a latex-safe environment.